![Laure Ory-Lavollée](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Laure Ory-Lavollée
Plus aucun poste en cours
Historique de carrière de Laure Ory-Lavollée
Anciens postes connus de Laure Ory-Lavollée
Sociétés | Poste | Début | Fin |
---|---|---|---|
Diatos SA
![]() Diatos SA Pharmaceuticals: MajorHealth Technology Diatos SA develops innovative therapies for the treatment of cancer. The firm leverages its peptide-based, intracellular drug delivery & tumor targeting technologies to improve the properties of existing therapeutics. Its products include DaunoXome, DTS-301 and DTS-108. The company was founded in 1999 and headquartered in Paris, France. | Directeur/Membre du Conseil | - | 15/09/2009 |
Puilaetco | Analyst-Equity | 15/05/2002 | 15/05/2002 |
CELLECTIS S.A. | Directeur/Membre du Conseil | - | - |
Statistiques
Internationale
France | 3 |
2 |
Opérationnelle
Director/Board Member | 2 |
Analyst-Equity | 1 |
Sectorielle
Health Technology | 3 |
Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
CELLECTIS S.A. | Health Technology |
Entreprise privées | 2 |
---|---|
Diatos SA
![]() Diatos SA Pharmaceuticals: MajorHealth Technology Diatos SA develops innovative therapies for the treatment of cancer. The firm leverages its peptide-based, intracellular drug delivery & tumor targeting technologies to improve the properties of existing therapeutics. Its products include DaunoXome, DTS-301 and DTS-108. The company was founded in 1999 and headquartered in Paris, France. | Health Technology |
Puilaetco | Finance |
- Bourse
- Insiders
- Laure Ory-Lavollée
- Expérience